These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37178784)

  • 21. Gonadotropin-releasing hormone agonist induces downregulation of tensin 1 in women with endometriosis.
    Rahmawati E; Yang WV; Lei YP; Maurya PK; Chen HW; Tzeng CR
    Acta Obstet Gynecol Scand; 2019 Feb; 98(2):222-231. PubMed ID: 30312486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current approaches to optimizing the treatment of endometriosis in adolescents.
    Laufer MR
    Gynecol Obstet Invest; 2008; 66 Suppl 1():19-27. PubMed ID: 18936548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of GnRHa therapy following conservative laparoscopic surgery for endometriosis on clinical pregnant rate in patients with endometriosis-associated infertility].
    He LQ; Cai XZ; Wang Y; Wang XF
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 May; 38(5):596-600. PubMed ID: 29891458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Add-back" therapy for endometriosis in adolescents.
    Lubianca JN; Gordon CM; Laufer MR
    J Reprod Med; 1998 Mar; 43(3):164-72. PubMed ID: 9564639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of long-term, low-dose gonadotropin-releasing hormone agonist therapy (draw-back therapy) for adenomyosis.
    Akira S; Mine K; Kuwabara Y; Takeshita T
    Med Sci Monit; 2009 Jan; 15(1):CR1-4. PubMed ID: 19114964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term gonadotropin-releasing hormone agonist therapy: the evolving issue of steroidal "add-back" paradigms.
    Adashi EY
    Keio J Med; 1995 Dec; 44(4):124-32. PubMed ID: 8587224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estroprogestin vs. gonadotrophin agonists plus estroprogestin in the treatment of endometriosis-related pelvic pain: a randomized trial. Gruppo Italiano per lo Studio dell'Endometriosi.
    Parazzini F; Di Cintio E; Chatenoud L; Moroni S; Ardovino I; Struzziero E; Falsetti L; Bianchi A; Bracco G; Pellegrini A; Bertulessi C; Romanini C; Zupi E; Massobrio M; Guidetti D; Troiano L; Beretta P; Franchi M
    Eur J Obstet Gynecol Reprod Biol; 2000 Jan; 88(1):11-4. PubMed ID: 10659911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term gonadotrophin-releasing hormone agonist therapy: the evolving issue of steroidal 'add-back' paradigms.
    Adashi EY
    Hum Reprod; 1994 Jul; 9(7):1380-97. PubMed ID: 7962453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of long-term use of combined oral contraceptive after gonadotropin-releasing hormone agonist plus add-back therapy versus dienogest to prevent recurrence of ovarian endometrioma after surgery.
    Seo JW; Lee DY; Kim SE; Yoon BK; Choi D
    Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():53-57. PubMed ID: 30884336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gonadotropin-releasing hormone agonist plus estrogen-progestin "add-back" therapy for endometriosis-related pelvic pain.
    Friedman AJ; Hornstein MD
    Fertil Steril; 1993 Aug; 60(2):236-41. PubMed ID: 8339817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the hemostatic effects of a levonorgestrel-releasing intrauterine system and leuprolide acetate in women with endometriosis: a randomized clinical trial.
    Yamaguti EM; Brito MB; Ferriani RA; Garcia AA; Rosa-e-Silva JC; Vieira CS
    Thromb Res; 2014 Dec; 134(6):1193-7. PubMed ID: 25283586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gonadotropin-releasing hormone agonist plus "add-back" hormone replacement therapy for treatment of endometriosis: a prospective, randomized, placebo-controlled, double-blind trial.
    Franke HR; van de Weijer PH; Pennings TM; van der Mooren MJ
    Fertil Steril; 2000 Sep; 74(3):534-9. PubMed ID: 10973651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current and Emerging Therapeutics for the Management of Endometriosis.
    Ferrero S; Barra F; Leone Roberti Maggiore U
    Drugs; 2018 Jul; 78(10):995-1012. PubMed ID: 29946962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Curative effect of 1.88-mg and 3.75-mg gonadotrophin-releasing hormone agonist on stage III-IV endometriosis: Randomized controlled study.
    Tang H; Wu R; Li X; Zhou Y; Liu Z; Wang C; Chen Y; Zhang F
    J Obstet Gynaecol Res; 2017 Oct; 43(10):1550-1554. PubMed ID: 28707810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Adjunctive treatment of GnRHa combined wenshen xiaozheng decoction in treating endometriosis after laparoscopy: a clinical observation].
    Ma XP; Cheng C; Zhang ZZ; Ye YQ; Wan GP
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Aug; 34(8):922-5. PubMed ID: 25223173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Efficacy of Postoperative Cyclic Oral Contraceptives after Gonadotropin-Releasing Hormone Agonist Therapy to Prevent Endometrioma Recurrence in Adolescents.
    Seo JW; Lee DY; Yoon BK; Choi D
    J Pediatr Adolesc Gynecol; 2017 Apr; 30(2):223-227. PubMed ID: 27744096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current and emerging treatment options for endometriosis.
    Ferrero S; Evangelisti G; Barra F
    Expert Opin Pharmacother; 2018 Jul; 19(10):1109-1125. PubMed ID: 29975553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regression of the inflammatory microenvironment of the peritoneal cavity in women with endometriosis by GnRHa treatment.
    Nirgianakis K; Bersinger NA; McKinnon B; Kostov P; Imboden S; Mueller MD
    Eur J Obstet Gynecol Reprod Biol; 2013 Oct; 170(2):550-4. PubMed ID: 23993133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Gonadotropin-Releasing Hormone Analogs on Ovarian Function Against Chemotherapy-Induced Gonadotoxic Effects in Premenopausal Women With Breast Cancer in China: A Randomized Clinical Trial.
    Zong X; Yu Y; Yang H; Chen W; Ding X; Liu S; Li X; Chen X; Jiang C; Xia X; Huang R; Zhu M; Hu J; Liang C
    JAMA Oncol; 2022 Feb; 8(2):252-258. PubMed ID: 34967844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in pharmacotherapy for treating endometriosis.
    Tafi E; Leone Roberti Maggiore U; Alessandri F; Bogliolo S; Gardella B; Vellone VG; Grillo F; Mastracci L; Ferrero S
    Expert Opin Pharmacother; 2015; 16(16):2465-83. PubMed ID: 26569155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.